BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Derycz Scientific (DYSE) CEO Named to 'PharmaVoice 100' for 2010


8/3/2010 7:19:45 AM

SANTA MONICA, Calif., Aug. 3 /PRNewswire-FirstCall/ -- Peter Derycz, CEO of Derycz Scientific, Inc. (OTC Bulletin Board: DYSC), a company that is pioneering a fresh way of facilitating the flow of information from content publishers to enterprise customers and their constituents, has been named to the "PharmaVoice 100" for 2010 by readers of PharmaVoice magazine. This honor is bestowed on those whom the magazine's readers judge as the 100 most inspiring people in the life sciences industry. A profile of Mr. Derycz appears in the July/August issue of PharmaVoice.

According to the profile, Mr. Derycz "started Derycz Scientific with a mission to bring published science to the masses ... While an initial online search may bring clients to the doorsteps of copyrighted materials, they still need services such as the ones offered by Derycz if they want to dig any deeper."

The profile additionally notes, "It takes a great leader to listen to good advice, draw knowledge from it, and put it into practice. It takes a truly in-touch leader to find lessons from all walks of life. Peter Derycz is just such an individual."

Commenting on the honor, Mr. Derycz stated, "Recognition by PharmaVoice of my role in the development of Derycz Scientific and its subsidiaries, like Reprints Desk, is a great way to raise our company's profile and to inform a wider circle of potential customers about our services. The attention garnered by this coverage may attract new companies to partner with us and help us advance their ability to handle a wide range of published materials."

To read the complete PharmaVoice profile of Mr. Derycz, please visit this link: http://www.pharmavoice.com/content/digital/welcome.html

Mr. Derycz's profile appears on page 76.

About Derycz ScientificĀ®

Derycz Scientific, Inc. (the "Company") develops companies, products, services and systems that facilitate the re-use of published content in a manner that helps organizations achieve their marketing, communication and research goals effectively and in compliance with copyright law and regulatory rules. Its subsidiary companies include Reprints Desk and Pools Press. Reprints Desk offers a one-stop solution for reprints, ePrints and single articles, and has delivered millions of articles worldwide. Reprint Desk is an innovator in content retrieval and ePrint delivery and its services are designed to help make effective use of published articles in a copyright-compliant manner. Pools Press has excelled in the reprint market for over 30 years. It provides professionally printed articles from medical and technical journals; prints booklets, catalogs, pamphlets, direct mail pieces, newsletters, and all business stationery; and works with publishers who wish to outsource a portion of or all of their reprints business. For more information, go to www.deryczscientific.com.

Forward-Looking Statements

As a cautionary note to investors, certain matters discussed in this press release may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such matters involve risks and uncertainties that may cause actual results to differ materially, including the following: changes in economic conditions; general competitive factors; acceptance of the Company's products in the market; the Company's success in technology and product development; the Company's ability to execute its business model and strategic plans; and all the risks and related information described from time to time in the Company's SEC filings, including the financial statements and related information contained in the Company's SEC Filing. The Company assumes no obligation to update the information in this release.

SOURCE Derycz Scientific, Inc.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES